Literature DB >> 28024647

Long-term Outcomes of Aflibercept Treatment for Neovascular Age-related Macular Degeneration in a Clinical Setting.

Dan Călugăru1, Mihai Călugăru1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 28024647     DOI： 10.1016/j.ajo.2016.11.022

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  4 in total

1.  High-frequency aflibercept injections in persistent neovascular age-related macular degeneration.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-08       Impact factor: 3.117

2.  Comment on "Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration".

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

3.  Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-08-21       Impact factor: 3.117

4.  The fate of eyes with wet AMD beyond 4 years of anti-VEGF therapy.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-05-07       Impact factor: 3.117
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.